Schizophrenia clinical trials - Search
Open links in new tab
  1. Schizophrenia: Four major clinical trials to watch in 2023

    • Learn about the novel mechanisms and endpoints of four late-stage trials in schizophrenia with readouts expected in 2023. The trials target total symptoms, negative symptoms, and treatment resistance of … See more

    Reviva, Newron, and Sunovion Target Total Symptoms

    In mid-2023, Reviva expects topline results for the 402-patient Phase III RECOVER trial of … See more

    Clinical Trials Arena
    Acadia Targets Negative Symptoms

    Acadia expects results in late 2023 or early 2024 for the 426-patient ADVANCE-2 trial of pimavanserin for the negative symptoms of schizophrenia (NCT04531982). Pimavanse… See more

    Clinical Trials Arena
    Drug Development in Schizophrenia

    Schizophrenia affects approximately 24 million people worldwide, and nearly one third of all cases go undiagnosed. Regulators have pushed strategies to improve cli… See more

    Clinical Trials Arena
    Feedback
     
  1. Bokep

    https://viralbokep.com/viral+bokep+terbaru+2021&FORM=R5FD6

    Aug 11, 2021 · Bokep Indo Skandal Baru 2021 Lagi Viral - Nonton Bokep hanya Itubokep.shop Bokep Indo Skandal Baru 2021 Lagi Viral, Situs nonton film bokep terbaru dan terlengkap 2020 Bokep ABG Indonesia Bokep Viral 2020, Nonton Video Bokep, Film Bokep, Video Bokep Terbaru, Video Bokep Indo, Video Bokep Barat, Video Bokep Jepang, Video Bokep, Streaming Video …

    Kizdar net | Kizdar net | Кыздар Нет

  2. Phase III trials of Reviva Pharmaceuticals’s brilaroxazine, Newron Pharmaceuticals ’s evenamide, and Sunovion Pharmaceuticals ’s ulotaront are each targeting total symptoms of schizophrenia. Meanwhile, Acadia Pharmaceuticals ’s pimavanserin focuses on the negative symptoms of schizophrenia, which include apathy, withdrawal, and blunted effect.
    www.clinicaltrialsarena.com/features/features-schiz…
    Currently, the standard clinical trial to assess the efficacy of a drug to treat schizophrenia lasts for six weeks after the onset of treatment, and patients are interviewed weekly by a trained rater to assess symptom severity with a test called the Positive and Negative Syndrome Scale (PANSS).
    www.fda.gov/drugs/regulatory-science-action/impro…
     
  3. People also ask
     
  4. Revolutionary drug for schizophrenia wins US approval - Nature

     
  5. Efficacy and Safety of Xanomeline-Trospium Chloride …

    This randomized clinical trial evaluates the efficacy and safety of xanomeline-trospium chloride vs placebo in adults with schizophrenia.

  6. Beyond antipsychotics: a twenty-first century update for preclinical ...

  7. Effectiveness of Antipsychotic Drugs in Patients with …

    Sep 22, 2005 · A total of 1493 patients with schizophrenia were recruited at 57 U.S. sites and randomly assigned to receive olanzapine (7.5 to 30 mg per day), perphenazine (8 to 32 mg per day), quetiapine (200...

  8. Schizophrenia - National Institute of Mental Health (NIMH)

  9. Systematic literature review of schizophrenia clinical …

    Feb 24, 2022 · Tani, H. et al. Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled...

  10. Efficacy and safety of the muscarinic receptor agonist KarXT ...

  11. Schizophrenia: Trial Results Show Advance in Cognition | BI US

  12. Improving Clinical Trials of Drugs to Treat Schizophrenia

  13. Current approaches to treatments for schizophrenia spectrum …

  14. Pimavanserin for negative symptoms of schizophrenia: results …

  15. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia

  16. Efficacy and effectiveness of antipsychotics in schizophrenia: …

  17. Schizophrenia Clinical Trials - Policy Lab

  18. A path to novel, effective treatments for schizophrenia - Nature

  19. UCLA Schizophrenia Clinical Trials for 2024 — Los Angeles

  20. Schizophrenia clinical trials at University of California Health - UC …

  21. UCSF Schizophrenia Clinical Trials — San Francisco Bay Area

  22. Schizophrenia Clinical Trials - Mayo Clinic Research

  23. UCSD Schizophrenia Clinical Trials for 2024 — San Diego

  24. Clinical Trials for Schizophrenia - WebMD

  25. The Norwegian standardization of the MATRICS (Measurement …